Trial Profile
A Randomised, Double-blind, Placebo-controlled Study to Assess the Effect of Oral, Single Dose 498 in a Validated Intranasal Capsaicin Challenge Model in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 705498 (Primary)
- Indications Rhinitis
- Focus Biomarker; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 11 Dec 2009 New trial record